MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,421
Beneficiaries
—
Total drug cost
$1.9M
Distinct drugs
33
Brand share
48.9%
Top prescribed drugs
Emtricitabine/Tenofov Alafenam335 claims
Emtricitabine/Tenofovir (Tdf)94 claims
Emtricitabine/Tenofovir (Tdf)92 claims
Aripiprazole84 claims
Escitalopram Oxalate77 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Alade Afolabi's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA | 30 | 48 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE